Stay updated on Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial
Sign up to get notified when there's something new on the Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial page.

Latest updates to the Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page has been updated to reflect a new completion status and a revised date of March 5, 2025, while removing the previous status of 'Active, not recruiting' and an earlier date of January 10, 2025.SummaryDifference1%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check46 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for the Help Desk.SummaryDifference6%
- Check53 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
- Check67 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check74 days agoChange DetectedThe website has added a new type of intervention in the latest update (v2.14.0) on January 10, 2025, while the previous version (v2.13.3) from October 15, 2024, has removed the same feature.SummaryDifference2%
Stay in the know with updates to Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial page.